Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Significant survival benefit in A-HeFT study of BiDil brings early conclusion

July 23, 2004

Mixed lineage kinase modulators described in a patent

July 22, 2004

Second phase I study planned for CTI-01

July 22, 2004

IND active for phase I/II study of TG-100-115

July 22, 2004

Enrollment underway in PRIMO-CABG-2 study of pexelizumab

July 22, 2004

Conclusion of phase II study of Liprostin for PVD

July 22, 2004

European approval for Teveten Plus

July 21, 2004

Phase IIb study of VEGF-2 for severe cardiovascular disease cleared to begin

July 20, 2004

New phase IIb study of darusentan for resistant systolic hypertension

July 20, 2004

Elafin completes preclinical testing

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...